Connect your AI

Pegasystems PEGA Accrued litigation

Accrued litigation at other companies

The Vita Coco Company, Inc.COCO

$0—

LQD

Liquidia CorporationLQDA

$8.55M+13.4%

Indivior Pharmaceuticals, Inc. INDV

$41M-86.2%

JAN

Janus Living JAN

$660K+1,220%

Amneal Pharmaceuticals, Inc.AMRX

$70.02M-4.1%

Service Corporation InternationalSCI

$19.05M+38.1%

Other financials

Income statement

Revenue$430.0M-9.6%

Gross profit$323.2M-13.4%

Operating income$37.1M-70.7%

Net income$32.8M-61.6%

EPS (diluted)$0.18-60.9%

Balance sheet

Cash & equivalents$274.3M+16.6%

Total debt$72.1M-9.0%

Total equity$705.9M+15.5%

Total assets$1.6B+17.3%

Cash flow

Operating cash flow$212.3M+3.9%

CapEx$5.7M+205%

Free cash flow$206.5M+2.1%

Valuation

Market cap$5.03B+20.5%

Enterprise value$4.83B+20.2%

P/E14.8×-6.5×

P/S3×+0.4×

Profitability

Gross margin75%-0.8pp

Operating margin10.2%-6.3pp

Net margin20%+8.1pp

FCF margin29.1%+7.1pp

Returns & leverage

Return on equity51.7%+12.5pp

Debt / equity0.1×0.0×

Current ratio1.2×-0.2×

Where this comes from

Reported directly by Pegasystems in its filing.

Tagged under the XBRL concept us-gaap:LitigationReserveCurrent.

The official record: Pegasystems’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pegasystems's accrued litigation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pegasystems's accrued litigation?: Pegasystems (PEGA) reported accrued litigation of $9.75M in Q1 2026.